Gunhild Mari Mælandsmo

9PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targetsLife cycle assessment and industrial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 14, 2026
DNA-Based Biomarkers as Predictors of Carboplatin Response in Neoadjuvant Treatment for Hormone Receptor Positive and Triple-Negative Breast Cancer.

|Nov 24, 2025
Spatial organization of the tumor-immune microenvironment in ER-positive breast cancer: remodeling during treatment and associations with clinical response.

Maria Aanesland Dahle, Jan-Lukas Førde, Eivind Valen Egeland

|Jul 28, 2025
Evaluation of HER2 Targeted Poly(Ethylene Glycol)-Poly(L-histidine) Copolymer Micelles in Breast Cancer Models.

Remya Valsala Kumari, Abhilash D Pandya, Solveig J Pettersen

|Dec 02, 2024
Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma.

Maite Emaldi, Esther Rey-Iborra, Ángela Marín

|Mar 27, 2023
A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases.

Vigdis Nygaard, Anne Hansen Ree, Vegar Johansen Dagenborg

|Sep 18, 2021
Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer.

Sigurdur Trausti Karvelsson, Qiong Wang, Bylgja Hilmarsdottir

Pageof 2

Frequent Collaborators

3 joint publications

Siver Moestue

3 joint publications

Lina Prasmickaite

3 joint publications

Mads Haugland Haugen

2 joint publications

Abhilash D Pandya